PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-20.50%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-37.39%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-101.25%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-101.25%
Negative operating income growth while OBE is at 255.00%. Joel Greenblatt would press for urgent turnaround measures.
-11.18%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-11.76%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-11.76%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.01%
Slight or no buybacks while OBE is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.01%
Diluted share count expanding well above OBE's 0.02%. Michael Burry would fear significant dilution to existing owners' stakes.
-0.01%
Dividend reduction while OBE stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
63.76%
OCF growth under 50% of OBE's 221.05%. Michael Burry might suspect questionable revenue recognition or rising costs.
41.12%
FCF growth under 50% of OBE's 180.00%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
-88.22%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-36.46%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-71.30%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-87.64%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-76.35%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-60.94%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-75.90%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
117.88%
5Y net income/share CAGR above 1.5x OBE's 35.99%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-92.02%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-73.12%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-4.54%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-44.15%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
-92.85%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-92.80%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-79.09%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-1.30%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
1.03%
Positive asset growth while OBE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
2.67%
BV/share growth above 1.5x OBE's 1.22%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
0.48%
We have some new debt while OBE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
23.91%
We expand SG&A while OBE cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.